SPRINT PNS is now recognized as a covered treatment option when medically necessary for certain patients with intractable neuropathic pain Under Aetna’s updated medical policy, the SPRINT PNS System ...
CLEVELAND, July 07, 2025 (GLOBE NEWSWIRE) -- Recently, ASPN published the first clinical guidelines focused specifically on the use of 60-day PNS (SPRINT PNS), offering evidence-based best practice ...
CLEVELAND, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Published in the journal Pain Medicine, “Comparison of Percutaneous 60-Day Peripheral Nerve Stimulation of the Lumbar Medial Branches to Usual Care with ...
CLEVELAND, March 04, 2026 (GLOBE NEWSWIRE) -- Shoulder pain is one of the most common locations of chronic pain. It impacts quality of life and has the potential to become disabling for millions of ...
CLEVELAND, Dec. 12, 2023 (GLOBE NEWSWIRE) -- SPR Therapeutics, Inc. today announced the final patient was enrolled in the RESET Clinical Trial of SPRINT ® PNS for the treatment of chronic low back ...
CLEVELAND, Ohio, April 25, 2023 (GLOBE NEWSWIRE) -- SPR ® Therapeutics, a private medical device company focused on treating pain and improving the quality of life for patients managing acute or ...
CLEVELAND, March 13, 2026 (GLOBE NEWSWIRE) -- SPR ®, a leading private medical device company focused on improving the lives of millions of people living with pain, announced that Aetna has published ...
(MENAFN- GlobeNewsWire - Nasdaq) - SPRINT PNS is now recognized as a covered treatment option when medically necessary for certain patients with intractable neuropathic pain - CLEVELAND, March 13, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results